|Product group||Main component||Indications and Contraindications||Storage and Handling|
|Algitab||Sodium alginate 50mg、Sodium bicarbonate 26.7mg、Calcium carbonate 16mg/mL||No specific contraindications.||Avoid direct sunlight exposure and store in cool places.|
|Alginos||Sodium alginate 50mg、Sodium bicarbonate 26.7mg、Calcium carbonate 16mg/mL||No specific contraindications. There are 141mg of sodium in a 10mL per unit. Please be advised for patients with certain cardiovascular, hepatic, or renal diseases.||Please store in temperature lower than 25℃. Do not refrigerate.|
INDICATIONS :Indications: Symptomatic relief of gastric juice and bile reflux into the esophagus.
|BIO-CAL PLUS||Tribasic calcium phosphate (equivalent to calcium 450mg) 1203mg Cholecalciferol 330IU||Contraindicated in patients with renal failure and known drug allergies.||Please store in cool environment and keep out of reach from children.|
INDICATIONS :Indications: Prevent calcium and vitamin D deficiency related diseases, such as osteoporosis.
|Cepiro||Cefpirome Sulfate eq. to cefpirome 1 G/ vial (potency)||Contraindicated in patients allergic to cephalosporin group antibiotics.||Please store in room temperature.|
INDICATIONS :Indications: Cepirome Sulfate susceptible bacterial infections.
|METACIN||Cefmetazole Sodium eq. to cefmetazole 0.5 g / vial (potency)||Contraindicated in patients allergic to cefmetazole.||Please store in room temperature.|
INDICATIONS :Indications: Infections caused by Staphylococcus, Streptococcus, Pneumococcus, Meningococcus, and other groups of susceptible bacteria.
|Sulfin||Sulfinpyrazone 100 mg / Tab||Contraindicated in patients with Peptic ulcer disease,gastroenteritis,or ulcer. Prohibited with following history: Allergy to phenylbutazone or other pyrazole class drugs,history of blood dyscrsias.||Please store in room temperature.|
INDICATIONS :Indications: Prohibited with patients with allergy to phenylbutazone or other pyrazole class drugs. Prohibited with patients with blood dyscrasias. Contraindicated in patients with Cancer undergoing radiation therapy or using rapid cytolytic agents; history of nephrolithiasis or urolithiasis, urate nephropathy.